2024-05-08T14:21:30-05:00 2023-12-31 390974031 WEGNER CPAS LLP 419 N LEE ST ALEXANDRIA VA 223142301 990 2023-01-01 232766566 SAFETY PHARMACOLOGY SOCIETY SAFE 7035470874 11190 SUNRISE VALLEY DRIVE 300 RESTON VA 20191 KRYSTLE CORRELL EXECUTIVE DIRECTOR 7035470874 2024-05-08 1 KRYSTLE CORRELL 999009999 1 GLENN MILLER CPA P00086726 7035190990 2024-05-01 2 AAL1 IAL1 2023 2023-04-26 12:10:37Z KRYSTLE CORRELL 11190 SUNRISE VALLEY DRIVE 300 RESTON VA 20191 883843 0 X WWW.SAFETYPHARMACOLOGY.ORG X 2000 PA TO PROMOTE THE AQUISITION AND UTILIZATION OF SCIENTIFIC INFORMATION; TO PROVIDE AN INTERACTIVE FORUM FOR THE ADVANCEMENT AND EXCHANGE OF INFORMATION AMONG ITS MEMBERS AND REPRESENTATIVES FROM INDUSTRY, ACADEMIA, AND GOVERNMENT. 15 15 0 140 9591 5611 46825 48030 513217 450501 23958 3826 0 2304 584000 504661 6100 11458 0 0 0 0 0 0 0 601044 678430 607144 689888 -23144 -185227 910542 800406 59019 49338 851523 751068 TO PROMOTE THE AQUISITION AND UTILIZATION OF SCIENTIFIC INFORMATION; TO PROVIDE AN INTERACTIVE FORUM FOR THE ADVANCEMENT AND EXCHANGE OF INFORMATION AMONG ITS MEMBERS AND REPRESENTATIVES FROM INDUSTRY, ACADEMIA, AND GOVERNMENT. 0 0 428282 11458 386735 ANNUAL MEETING - PRESENTATION AND EXCHANGE OF SCIENTIFIC INFORMATION. 70577 0 49250 COMMITTEES - PROMOTE RESEARCH, EDUCATION, AND DISSEMINATION OF SCIENTIFIC INFORMATION. 29244 0 4925 LONG RANGE PLANNING - INITIATIVES RELATED TO FURTHERING THE GOALS OF PROMOTING KNOWLEDGE, DEVELOPMENT, APPLICATION, AND TRAINING IN THE FIELD OF SAFETY PHARMACOLOGY. 528103 1 1 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 1 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 3 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 X 15 15 0 1 0 0 1 1 1 1 1 0 0 1 1 1 1 1 1 0 0 0 VA X ASSOCIATION INNOVATION MANAGEMENT 7034383103 11190 SUNRISE VALLEY DR STE 300 RESTON VA 20191 X MARIE-LUCE BRODZINSKI-ROSSEELS PRESIDENT 1.00 X X 0 0 0 SIMON AUTHIER VICE PRESIDENT 1.00 X X 0 0 0 ANDREA GREITER-WILKE VICE PRESIDENT-ELECT 1.00 X X 0 0 0 ANNIE DELAUNOIS TREASURER 1.00 X X 0 0 0 C MIKE FOLEY TREASURER-ELECT 1.00 X X 0 0 0 DINAH MISNER SECRETARY 1.00 X X 0 0 0 TODD WISIALOWSKI PAST PRESIDENT 1.00 X X 0 0 0 ALEXIS ASCAH DIRECTOR 1.00 X 0 0 0 KHURAM CHAUDHARY DIRECTOR 1.00 X 0 0 0 KIM HENDERSON DIRECTOR 1.00 X 0 0 0 LASSE SKIBSBYE DIRECTOR 1.00 X 0 0 0 PHIL ATTERSON DIRECTOR 1.00 X 0 0 0 SONIA ROBERTS DIRECTOR 1.00 X 0 0 0 YASUNARI KANDA DIRECTOR 1.00 X 0 0 0 TESSA DE KORTE DIRECTOR 1.00 X 0 0 0 KRYSTLE CORRELL EXECUTIVE DIRECTOR 15.00 X 0 0 0 0 0 0 0 0 0 0 ASSOCIATION INNOVATION AND MANAGEMENT I 11190 SUNRISE VALLEY DRIVE SUITE 3 RESTON VA 20191 MANAGEMENT SERVICES 344030 1 48030 48030 ANNUAL MEETING 900099 384490 384490 MEMBERSHIP DUES 900099 49250 49250 ADVERTISING 541800 9591 9591 7170 7170 450501 33459 33459 349549 379182 -29633 -29633 -29633 2304 0 2304 2304 504661 440910 9591 6130 1500 1500 9958 9958 40207 40207 8025 8025 3866 3866 43957 19333 24624 8156 3638 4518 40288 31454 8834 12201 4818 7383 25593 25593 459873 418842 41031 140 140 5498 4086 1412 MEMBERSHIP SERVICES 17026 17026 DUES AND SUBSCRIPTIONS 10031 8881 1150 TAXES 3362 3362 NEWSLETTER 207 207 689888 528103 161785 0 34070 34596 3406 0 26300 3769 87322 64988 19993 19795 338 198 724783 685302 34323 11553 910542 800406 33009 18138 26010 31200 59019 49338 X 849752 751068 1771 0 851523 751068 910542 800406 -185227 84772 0 X 0 0 0 X 106875 42371 45625 46825 48030 289726 491192 271103 294586 493700 440910 1991491 2304 2304 598067 313474 340211 540525 491244 2283521 0 0 0 2283521 26922 32183 24863 29692 33459 147119 26922 32183 24863 29692 33459 147119 8872 11290 10817 5611 36590 633861 345657 376364 581034 530314 2467230 0.92550 0.93270 0.05960 0.05410 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 19993 19795 198 198 1 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 PROGRAM SERVICES ANNUAL MEETING 196941 NORTH AMERICA 0 0 PROGRAM SERVICES ANNUAL MEETING 7934 EAST ASIA AND THE PACIFIC 0 0 PROGRAM SERVICES ANNUAL MEETING 1070 EUROPE (INCLUDING ICELAND & GREENLAND) 0 0 GRANTS TO RECIPIENTS 8458 EAST ASIA AND THE PACIFIC 0 0 GRANTS TO RECIPIENTS 1500 0 0 0 0 0 0 215903 0 215903 TRAVEL AWARDS EUROPE (INCLUDING ICELAND & GREENLAND) 7 7858 WIRE TRANSFER TRAVEL AWARDS EAST ASIA AND THE PACIFIC 1 1500 WIRE TRANSFER POSTER AWARDS EUROPE (INCLUDING ICELAND & GREENLAND) 3 600 WIRE TRANSFER 0 0 0 0 0 0 PART I, LINE 2: AS A NONPROFIT ORGANIZATION COMMITTED TO ADVANCING SCIENTIFIC KNOWLEDGE AND FACILITATING COLLABORATION WITHIN THE GLOBAL RESEARCH COMMUNITY, WE ADHERE TO STRICT PROCEDURES FOR MONITORING THE USE OF GRANTS AND OTHER FINANCIAL ASSISTANCE PROVIDED BY EXTERNAL SOURCES, INCLUDING MEETING SUPPORT GRANTS AWARDED BY PHARMACEUTICAL COMPANIES. WHEN WE RECEIVE FINANCIAL SUPPORT FOR OUR SCIENTIFIC MEETINGS OR OTHER PROGRAMS FROM PHARMACEUTICAL COMPANIES, WE ENSURE THAT THE FUNDS ARE UTILIZED IN ACCORDANCE WITH THE TERMS OUTLINED IN THE LETTER OF AGREEMENT (LOA) OR ANY OTHER RELEVANT CONTRACTUAL AGREEMENTS. THIS INCLUDES GRANTS ALLOCATED FOR MEETINGS HELD OUTSIDE OF THE UNITED STATES. OUR MONITORING PROCEDURES FOR GRANTS/OTHER ASSISTANCE OUTSIDE OF THE U.S. ARE CONSISTENT WITH THOSE APPLIED TO DOMESTIC GRANTS, REFLECTING OUR COMMITMENT TO TRANSPARENCY, ACCOUNTABILITY, AND ETHICAL CONDUCT IN ALL ASPECTS OF OUR OPERATIONS. THESE PROCEDURES INCLUDE: 1. DETAILED BUDGETING AND DOCUMENTATION: WE MAINTAIN COMPREHENSIVE RECORDS OF BUDGET ALLOCATIONS, EXPENDITURES, AND RECEIPTS RELATED TO ALL GRANTS AND FINANCIAL ASSISTANCE RECEIVED, REGARDLESS OF THE LOCATION OF THE FUNDED ACTIVITIES. WHEN REQUESTING SUPPORT FOR A MEETING OUTSIDE OF THE U.S. WE PROVIDE DETAILED INFORMATION ABOUT THE LOCATION TO THE SUPPORTER IN OUR APPLICATION, AND OFTEN WORK DIRECTLY WITH THE COMPANY'S GLOBAL SECTOR (VS. U.S. ONLY) FOR THESE REQUESTS. 2. REGULAR REPORTING: WE PROVIDE REGULAR REPORTS TO OUR FUNDERS, INCLUDING PHARMACEUTICAL COMPANIES, DETAILING HOW THEIR FINANCIAL SUPPORT HAS BEEN UTILIZED. THESE REPORTS INCLUDE BREAKDOWNS OF EXPENSES, PROGRAM OUTCOMES, AND ANY DEVIATIONS FROM THE AGREED-UPON BUDGET OR SCOPE OF WORK. WE ALSO TYPICALLY ARE REQUIRED TO SUBMIT A RECONCILIATION OR CLOSE OUT OF THE ACTIVITY WITH EACH SUPPORTER. 3. COMPLIANCE OVERSIGHT: OUR ORGANIZATION HAS ESTABLISHED INTERNAL CONTROLS AND OVERSIGHT MECHANISMS TO ENSURE COMPLIANCE WITH APPLICABLE LAWS, REGULATIONS, AND ETHICAL GUIDELINES, BOTH DOMESTICALLY AND INTERNATIONALLY. THIS INCLUDES MONITORING FOR ANY POTENTIAL CONFLICTS OF INTEREST OR IMPROPER USE OF FUNDS. 4. COMMUNICATION AND TRANSPARENCY: WE MAINTAIN OPEN LINES OF COMMUNICATION WITH OUR FUNDERS, RESPONDING PROMPTLY TO INQUIRIES AND PROVIDING UPDATES ON THE PROGRESS OF FUNDED ACTIVITIES. TRANSPARENCY IS PARAMOUNT IN OUR RELATIONSHIPS WITH PHARMACEUTICAL COMPANIES AND OTHER DONORS. FORM 990, PART VI, SECTION A, LINE 3 THE SOCIETY USES A MANAGEMENT FIRM FOR DUTIES TYPICALLY PERFORMED BY AN EXECUTIVE DIRECTOR, ACCOUNTING AND SUPPORT STAFF. FORM 990, PART VI, SECTION A, LINE 6 THE SOCIETY HAS MEMBERS WITH VOTING RIGHTS IN THE FOLLOWING CATEGORIES: INDIVIDUAL MEMBER, STUDENT MEMBER, RETIRED MEMBER, HONORARY MEMBER, EMERITUS MEMBER, OR CHARTER MEMBER. FORM 990, PART VI, SECTION A, LINE 7A THE SOCIETY HAS VOTING MEMBERS WHO MAY ELECT THE BOARD OF DIRECTORS. FORM 990, PART VI, SECTION A, LINE 7B THE SOCIETY HAS MEMBERS WHO EACH HAVE THE RIGHT TO CAST ONE VOTE ON ANY MOTION THAT MAY BE PROPERLY BROUGHT BEFORE THE SOCIETY, INCLUDING EXPULSION OF A MEMBER. FORM 990, PART VI, SECTION B, LINE 11B THE FINANCE COMMITTEE AND THE TREASURER REVIEW THE 990 AND THE EXECUTIVE DIRECTOR SIGNS IT. FORM 990, PART VI, SECTION B, LINE 12C EACH MEMBER STATES ANY CONFLICTS OF INTEREST AT THE FIRST CALL OF THE YEAR. ALL BOARD MEMBERS ARE THEN ENCOURAGED TO DISCLOSE CONFLICTS THAT ARISE DURING THE YEAR. FORM 990, PART VI, SECTION C, LINE 19 THE CONSTITUTION AND BY-LAWS ARE AVAILABLE ON THE SOCIETY'S WEBSITE, WWW.SAFETYPHARMACOLOGY.ORG; THE CONFLICT OF INTEREST POLICY AND FINANCIAL STATEMENTS ARE AVAILABLE UPON REQUEST.